Literature DB >> 20362693

Pharmacophore modeling and applications in drug discovery: challenges and recent advances.

Sheng-Yong Yang1.   

Abstract

Pharmacophore approaches have become one of the major tools in drug discovery after the past century's development. Various ligand-based and structure-based methods have been developed for improved pharmacophore modeling and have been successfully and extensively applied in virtual screening, de novo design and lead optimization. Despite these successes, pharmacophore approaches have not reached their expected full capacity, particularly in facing the demand for reducing the current expensive overall cost associated with drug discovery and development. Here, the challenges of pharmacophore modeling and applications in drug discovery are discussed and recent advances and latest developments are described, which provide useful clues to the further development and application of pharmacophore approaches. (c) 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20362693     DOI: 10.1016/j.drudis.2010.03.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  132 in total

1.  Discovery of new Mycobacterium tuberculosis proteasome inhibitors using a knowledge-based computational screening approach.

Authors:  Rukmankesh Mehra; Reena Chib; Gurunadham Munagala; Kushalava Reddy Yempalla; Inshad Ali Khan; Parvinder Pal Singh; Farrah Gul Khan; Amit Nargotra
Journal:  Mol Divers       Date:  2015-08-01       Impact factor: 2.943

Review 2.  Substrate tunnels in enzymes: structure-function relationships and computational methodology.

Authors:  Laura J Kingsley; Markus A Lill
Journal:  Proteins       Date:  2015-02-28

Review 3.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

5.  Identification of New Human Malaria Parasite Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening.

Authors:  Elumalai Pavadai; Farah El Mazouni; Sergio Wittlin; Carmen de Kock; Margaret A Phillips; Kelly Chibale
Journal:  J Chem Inf Model       Date:  2016-03-08       Impact factor: 4.956

6.  Targeting the target of rapamycin (TOR): looking to mother nature.

Authors:  Eric K Rowinsky
Journal:  Target Oncol       Date:  2011-04-27       Impact factor: 4.493

7.  Ensemble pharmacophore meets ensemble docking: a novel screening strategy for the identification of RIPK1 inhibitors.

Authors:  S M Fayaz; G K Rajanikant
Journal:  J Comput Aided Mol Des       Date:  2014-07-01       Impact factor: 3.686

8.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

9.  Role of the CAI-1 fatty acid tail in the Vibrio cholerae quorum sensing response.

Authors:  Lark J Perez; Wai-Leung Ng; Paul Marano; Karolina Brook; Bonnie L Bassler; Martin F Semmelhack
Journal:  J Med Chem       Date:  2012-11-08       Impact factor: 7.446

10.  BCL::MolAlign: Three-Dimensional Small Molecule Alignment for Pharmacophore Mapping.

Authors:  Benjamin P Brown; Jeffrey Mendenhall; Jens Meiler
Journal:  J Chem Inf Model       Date:  2019-02-12       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.